Considering this evidence, FH genetic testing is recommended to confirm FH diagnosis or variant carrier status in clinically-suspected cases, especially cases involving very early-onset CAD where clinical signs of FH are less overt [31]. The gene discussed is FH; the disease is familial hyperaldosteronism.